Director/PDMR Shareholding

Medica

21/10/2022 15:26

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221021:nRSU7667Da&default-theme=true

RNS Number : 7667D  Medica Group PLC  21 October 2022

Medica Group PLC

Director / PDMR / PCA Shareholding

Medica Group Plc (LSE:MGP), the UK and Ireland market leader in the provision
of teleradiology services, announces that it was notified on 21 October 2022
that Ms Mallika Kaviratne, the spouse of Dr Stuart Quin, Chief Executive
Officer of Medica, purchased a total of 59,900 ordinary shares of 0.2p in the
Company ("Shares") at a price of 125 pence per Share.

Following this transaction, Stuart Quin is beneficially interested in 177,480
shares, representing 0.1% of the issued share capital of the Company.

The notification set out below are provided in accordance with the
requirements of the UK Market Abuse Regulation and set out more details of the
transactions.

   1    Details of the person discharging managerial responsibilities / person closely

      associated

 a)     Name                                                         Mallika Kaviratne

 2      Reason for the notification

 a)     Position/status                                              PCA of Dr Stuart Quin, Chief Executive Officer

 b)     Initial notification /Amendment                              Initial notification

 3      Details of the issuer, emission allowance market participant, auction

      platform, auctioneer or auction monitor

 a)     Name                                                         Medica Group PLC

 b)     LEI                                                          213800B8XE5FUSZF5Z16

 4      Details of the transaction(s): section to be repeated for (i) each type of

      instrument; (ii) each type of transaction; (iii) each date; and (iv) each
        place where transactions have been conducted

 a)     Description of the financial instrument, type of instrument  Ordinary shares of 0.2p

                                                                     GB00BYV24996

 b)     Nature of the transaction                                    Market purchase

 c)     Price(s) and volume(s)                                       Price (s)  Volumes (s)

                                                                   125.00     59,900

 d)     Aggregated information

Price (s)  Volumes (s)
        -     Aggrated volume                                        125.00     59,900

        -     Price

 e)     Date of the transaction                                      21 October 2022

 f)     Place of the transaction                                     XLON

 

 

 

 

 

d)

 

Aggregated information

-     Aggrated volume

-     Price

 

 

 Price (s)  Volumes (s)
 125.00     59,900

e)

 

Date of the transaction

 

 

21 October 2022

f)

 

Place of the transaction

 

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBKDBBQBDDPKB